Short communication · 30 Jul 2026
Review articlePublished 2016
Current Treatment of Schizoaffective Disorder According to a Neural Network
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Schizoaffective disorder, which is combined with schizophrenic and affective, i.e. depressive or manic or alternating depressive and manic symptoms, has a prevalance of 0.5%. Here, we describe the alterations of the most important classical neurotransmitters in the brain regions involved in schizophrenic and affective symptoms. Schizoaffective is undoubtedly an inheritable chronic psychiatric disease, whereby traumata can enhance schizophrenic and affective symptoms in one third of patients. Neural networks are described in the brainstem, hippocampus and ventral tegmental area and the mentioned neurotransmitter alterations are considered. Prophylactic treatment of schizoaffective patients consists of administering mostly second-generation antipsychotic drugs alone or in combination with mood-stabilizing drugs. The clinical importance of the antipsychotic drug clozapine for a pharmacotherapy of treatment-resistant forms of the disease is underlined.
Keywords
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Cytology & Histology.
Commentary · 29 Nov 2025
Cytology: Diagnosing Head and Neck Lesions and Tumors
Commentary · 29 Nov 2025
Histological Insights: Unraveling Human Disease Pathology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cytology & Histology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Felix-Martin Werner”
- BylineArticles whose byline prints “Rafael Covenas”
